Published in Sci Transl Med on May 04, 2011
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Engineering nano- and microparticles to tune immunity. Adv Mater (2012) 1.75
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano (2014) 0.96
The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis. Front Immunol (2015) 0.92
Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. Angew Chem Int Ed Engl (2013) 0.90
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers. EMBO Mol Med (2012) 0.85
The key role of the scaffold on the efficiency of dendrimer nanodrugs. Nat Commun (2015) 0.81
Recent advances in targeted drug delivery approaches using dendritic polymers. Biomater Sci (2014) 0.81
Polymeric drugs: Advances in the development of pharmacologically active polymers. J Control Release (2015) 0.81
Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury. J Control Release (2015) 0.80
Nanomedicine in cerebral palsy. Int J Nanomedicine (2013) 0.80
Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent. Arthritis Res Ther (2014) 0.78
Nanoscale effects in dendrimer-mediated targeting of neuroinflammation. Biomaterials (2016) 0.78
Experimental arthritis: Dendrimer drug mends monocytes. Nat Rev Rheumatol (2011) 0.77
GATG dendrimers and PEGylated block copolymers: from synthesis to bioapplications. AAPS J (2014) 0.76
Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release (2017) 0.75
Nanoparticles and direct immunosuppression. Exp Biol Med (Maywood) (2016) 0.75
Particle-based technologies for osteoarthritis detection and therapy. Drug Deliv Transl Res (2016) 0.75
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles. Nanomaterials (Basel) (2017) 0.75
Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo. Proc Natl Acad Sci U S A (2017) 0.75
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine (2006) 1.77
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum (2002) 1.57
In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol (2005) 1.57
What lessons can be learned from γδ T cell-based cancer immunotherapy trials? Cell Mol Immunol (2012) 1.54
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. J Rheumatol (2006) 1.53
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev (2007) 1.50
Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion. Joint Bone Spine (2010) 1.46
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine (2007) 1.44
Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J Rheumatol (2002) 1.43
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol (2007) 1.42
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clin Exp Rheumatol (2012) 1.42
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res (2012) 1.38
Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med (2011) 1.38
Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine (2010) 1.37
Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol (2002) 1.29
Human gamma delta T cells induce dendritic cell maturation. Clin Immunol (2002) 1.29
Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther (2006) 1.27
Simultaneous excitation of propagating and localized surface plasmon resonance in nanoporous gold membranes. Anal Chem (2006) 1.27
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood (2004) 1.27
Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum (2002) 1.26
Dendrimeric coating of glass slides for sensitive DNA microarrays analysis. Nucleic Acids Res (2003) 1.25
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies. Blood (2009) 1.24
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.23
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Res Ther (2008) 1.22
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann Rheum Dis (2010) 1.20
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol (2003) 1.18
Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One (2008) 1.17
A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum (2006) 1.17
New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther (2008) 1.17
The role of toll-like receptors in systemic lupus erythematosus. Springer Semin Immunopathol (2006) 1.16
The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol (2009) 1.16
Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine (2006) 1.16
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med (2008) 1.14
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery. Clin Immunol (2008) 1.13
Rituximab inhibits B-cell receptor signaling. Blood (2009) 1.13
Accelerated atherosclerosis in ApoE deficient lupus mouse models. Clin Immunol (2008) 1.11
B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice. J Immunol (2008) 1.11
Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum (2005) 1.09
Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J Immunol (2008) 1.07
Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum (2009) 1.06
Characterization of dendrimers. Adv Drug Deliv Rev (2005) 1.06
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma (2011) 1.06
Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect (2005) 1.05
Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol (2002) 1.05
Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem (2002) 1.05
The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol (2008) 1.04
T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol (2008) 1.04
Stimulated γδ T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer. J Immunol (2011) 1.04
Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Res Ther (2007) 1.04
Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med (2003) 1.03
A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells. Eur J Immunol (2009) 1.02
PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochem Pharmacol (2010) 1.01
Acquisition of viral receptor by NK cells through immunological synapse. J Immunol (2003) 1.01
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Joint Bone Spine (2007) 1.01
Phosphoantigen presentation by macrophages to mycobacterium tuberculosis--reactive Vgamma9Vdelta2+ T cells: modulation by chloroquine. Infect Immun (2002) 1.00
The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures. Eur J Immunol (2011) 0.99
Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis (2012) 0.99
Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) (2011) 0.99
Osteoid osteoma of the carpal bones. Two case reports. Joint Bone Spine (2006) 0.98
Synthesis and properties of dendrimers possessing the same fluorophore(s) located either peripherally or off-center. J Org Chem (2007) 0.98
Escherichia coli produces phosphoantigens activating human gamma delta T cells. J Biol Chem (2001) 0.97
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Adv Drug Deliv Rev (2013) 0.97
Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J Autoimmun (2010) 0.96
Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease? Clin Rheumatol (2004) 0.96
Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol (2007) 0.96
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis (2012) 0.96
Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol (2006) 0.95
Active trans-synaptic capture of membrane fragments by natural killer cells. Eur J Immunol (2002) 0.94
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine (Baltimore) (2015) 0.94
Water-soluble dendrimeric two-photon tracers for in vivo imaging. Angew Chem Int Ed Engl (2006) 0.92
Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens. J Immunol (2002) 0.92
Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes. J Immunol (2003) 0.91
Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity. J Virol (2004) 0.91
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer (2010) 0.91
The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol (2005) 0.90
Spontaneous membrane transfer through homotypic synapses between lymphoma cells. J Immunol (2003) 0.90